JOHN CRAIG THOMPSON
CIK 1509643 · President & CEO · last filed 2026-06-01
JOHN CRAIG THOMPSON is a President & CEO who has filed 24 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for ESPR, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $251.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$251.6K
4
24
-$3.93M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 79,873 | $3.15 | $251.6K | $0 | 2 | 2026-06-01 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | President & CEO | 19,848 | — | — | $26.2K | 9 | 2018-01-09 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Chief Operating Officer | 10,343 | — | — | -$3.96M | 8 | 2015-09-10 |
| Trius Therapeutics Inc (TSRX) Delisted | Chief Commercial Officer | 133 | — | — | $862 | 4 | 2013-03-11 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | ESPR | Grant (A) | +79,873 | $0 | EDGAR |
| 2025-07-02 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-20 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Buy (P) | +8,550 | $11.3K | EDGAR |
| 2017-09-07 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Buy (P) | +10,400 | $14.9K | EDGAR |
| 2017-09-07 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Exer (M) | +10,400 | $14.9K | EDGAR |
| 2017-05-22 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-06 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |